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Abstract
Background: Hepatitis B virus (HBV) infection in Nigeria has remained a Public Health issue. It is a major cause of
mortality, especially in developing countries. Vertical transmission of hepatitis B virus infection is thought to be
a major route of transmission in low resource areas. In spite of this, routine antenatal screening for hepatitis B
infection is not yet practiced in many Nigerian hospitals. This paper present the findings of a study conducted
among antenatal women in Nnewi, Nigeria.
Methods: It was a cross-sectional study carried out over a 3-month period (August - October, 2009). Recruitment
of 480 women attending antenatal clinics in Nnewi, Nigeria was done by simple random sampling using computer
generated random numbers. HBsAg screening was done using rapid ELISA Kits. Statistical analysis was computed
using STATA 11 package. The results were subjected to analysis using cross tabulations to explore statistical
relationships between variables. Chi square test was used to explore proportional relationship between groups. The
level of statistical significance was set at p < 0.05 (providing 95% confidence interval).
Results: Four hundred and eighty pregnant women were recruited into the study. Of these, 40 tested positive to
HBsAg, accounting for 8.3% of the sample population. The age of the subjects studied varied from 14 to 45 years
(mean age - 24.3 years) while the mean parity was 2.18. The HIV/HBV co-infection rate was 4.2%. The vertical
transmission rate was 51.6%. There were statistically significant relationships between HBV infection and previous
history of tribal marks/tattoos (c
2 = 27.39, P = 0.001, df = 1), history of contact with previously infected HBV
patients (c
2 = 23.11, P = 0.001, df = 1) and occupation of the women (c
2 = 51.22, P = 0.001, df = 1). Multiple sexual
partners, blood transfusion, dental manipulations, sharing of sharps/needles, and circumcision were not significant
modes of transmission. There was no statistically significant relationship between maternal age, educational level
and HBV infection.
Conclusion: The authors argued that hepatitis B screening in pregnancy should be made routine practice in
Nigeria because of the low pick up rate of the infection based only on risk factors for the disease.
Introduction
Infection with hepatitis B virus (HBV) is a serious global
public health problem [1-3]. In the continents of Africa
and Asia, it remains a major cause of morbidity and
mortality [1-3]. Annually, up to 1 million of these
infected population die due to the consequences of the
infection such as liver cirrhosis and hepatocellular carci-
noma [4]. Despite the existence of a safe and effective
vaccine, Nigeria has remained a hyper-endemic area for
hepatitis B virus infection, with an estimated 12% of the
total population being chronic carriers [5]. Hepatitis B
virus infection continues to be a substantial and devas-
tating health problem, with new cases still being
reported annually [6,7].
The prevalence of HBV infection among an antenatal
population may be a reliable indicator of hepatitis B virus
prevalence rate in the general population. Hence, screen-
ing antenatal women for HBsAg can give a reliable preva-
lence of the disease in a population and provide an
avenue for preventing mother to child transmission of
t h ev i r u s .AD e m o g r a p h i cH e a l t hS u r v e y( D H S )b yt h e
World Health Organization (WHO) in 2003 showed that
in the developing countries of Africa, 68% of women
report at least one ante-natal visit [8]. This study by the
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women reported for antenatal care four or more times in
Nigeria [8]. 74% of these women who accessed antenatal
care in Nigeria are from the urban areas while 44% are
from the rural areas [8]. The study showed that women
presenting for antenatal care in Nigeria are most likely to
wait until the second trimester and a relatively substantial
proportion present only in the third trimester [8]. It has
also been shown that vertical transmission of hepatitis B
virus occur in up to 10% of neonates when the infection
occur in the first trimester and in 60% to 90% of babies
in the third trimester [9].
Sero-prevalence studies on HBsAg in Nigeria have
shown that the prevalence of the infection in pregnant
women range from 2-15% [10-13]. Screening for HBsAg
is routine in pregnancy in most developed countries of
the world. It is a recommendation of the Royal College
of Obstetricians and Gynaecologists (RCOG) of the Uni-
ted Kingdom [14], the American College of Obstetrics
and Gynecology (ACOG) [15], and most of the other
1 2 2C o l l e g e so fO b s t e t r i c sa n dG y n e c o l o g ya l lo v e rt h e
world to screen pregnant women for hepatitis B surface
antigen routinely in pregnancy. However, in Nigeria,
screening of antenatal women for hepatitis B virus is
not a routine practice. Also, routine vaccination of new-
borns is not widely available in low resource settings in
Nigeria. Even though Nigeria approved the inclusion of
hepatitis B vaccine in its National Program on Immuni-
zation (NPI) in 1995, the vaccine only became widely
available in 2004 [16]. Despite the fact that the vaccine
had been made available via the NPI, immunization cov-
erage for Hepatitis B is still not optimal in low resource
settings in Nigeria [16]. A recent study in Nigeria
showed that the Hepatitis B vaccine coverage rate in
low resource settings is currently about 41% [17]. The
consequences of the problems of low pick up rate of
HBV infection due to poor screening and the low vacci-
nation rate are that vertical transmission of hepatitis B
virus has become the major route of transmission of the
virus in Nigeria. This has a major impact on the babies
when born because of the risk to developing chronic
liver diseases later in life.
Acute hepatitis in pregnancy has been shown to
induce premature labour and prematurity with its atten-
dant effects [9,18]. Studies have shown an increase in
the incidence of prematurity over that seen in the gen-
eral population [9,18,19]. The Apgar scores were also
shown to be lower in the newborn of HBsAg carriers,
and there was a higher risk of intra-ventricular hemor-
rhage as well, which was probably related to the higher
incidence of preterm delivery [19]. Apart from this,
intra-partum and post-partum hemorrhage from coagu-
lation failure due to lack of production of vitamin K
dependent clotting factors, especially if the prothrombin
time is prolonged as in fulminant hepatic failure, are
problems that could present following chronic hepatitis
B virus infection. Again, in utero infection with Hepati-
tis B virus remains very important because some fetuses
that contact the hepatitis B antigen early in embryonic
development become immunologically tolerant to the
antigen, leading to a chronic HBV infection caused by
the inability to eliminate the virus [18].
Prevention of vertical transmission is extremely
important because HBV infection in early life can result
in a chronic carrier state. As s h o w ni ne a r l i e rs t u d i e s ,
administration of hepatitis B immunoglobulin (HBIG) to
HBsAg-positive mothers reduced the rate of vertical
transmission to 23%, and the combination of HBIG
and hepatitis B vaccination reduced transmission
even further to 3% [18,20]. Passive-active immuno-
prophylaxis with hepatitis B immunoglobulin (HBIG)
and hepatitis B vaccine in the infants of HBV carriers
gives high levels of protection against vertical transmis-
sion [18]. Administration of HBIG in a dose of 200
international units, intramuscularly every week from
28th weeks of gestation reduces mother to child trans-
mission of hepatitis B virus [9,18,21]. Lamivudine, a
cytosine analogue that acts as a nucleoside reverse tran-
scriptase inhibitor, is a potent inhibitor of HBV replica-
tion [22]. Lamivudine therapy leads to rapid reduction
of HBV-DNA levels, with a median reduction of 97%
after 2 weeks [9]. It has been used with good safety and
efficacy in the last four weeks of pregnancy to decrease
the risks of vertical transmission [9,22]. Li et al, in 2003
showed that intrauterine infection was reduced to 16.3%
against 32.7% (controls) with the use of lamivudine from
the 28th week of gestation at a dose of 100 mg/day [23].
The role of Caesarean section in reducing mother to
child transmission of HBsAg has been studied and it
was found that it does not show any extra reduction in
the incidence of immunoprophylaxis failure in com-
parison to vaginal delivery. There is no evidence that
Caesarean section prevents maternal-infant transmission
of hepatitis B virus [9,14,18].
Since hepatitis B virus infection has serious sequelae,
there is a continuing need to examine its epidemiology,
especially in low resource settings in Nigeria. The
Objective of this study therefore, was to determine the
prevalence, correlates and pattern of Hepatitis B surface
antigen among pregnant women attending antenatal
clinics at the Nnamdi Azikiwe University Teaching Hos-
pital, Nnewi, Nigeria. This centre is also dedicated to
the Prevention of Mother To Child Transmission of
HIV (PMTCT), so we handle a significant number of
HIV positive pregnant women as well. Therefore, the
study compared the prevalence of Hepatitis B surface
antigen among the HIV sero-negative and HIV sero-
positive patients.
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It was a cross-sectional study, conducted at the Nnamdi
Azikiwe University Teaching Hospital, Nnewi, Nigeria.
Nnamdi Azikiwe University Teaching Hospital, Nnewi is
a center for the Prevention of Mother to Child Trans-
mission of HIV (PMTCT) for the south eastern geo-
political zone in Nigeria. The study was carried out
among pregnant women attending antenatal care at the
Nnamdi Azikiwe University Teaching Hospital, Nigeria.
The research was conducted after approval was
obtained from the ethics and research committee of the
hospital. The study recruited 480 pregnant women
attending antenatal clinics at the Nnamdi Azikiwe
University Teaching Hospital, Nnewi by simple random
sampling using computer generated random numbers.
The sample size was derived using the formula for sam-
ple size calculation: N = z
2pq/d
2 (where z = Standard
normal deviation at 1.96 (which corresponds to 95%
confidence interval; p = Prevalence of Hepatitis B sur-
face antigen in ante-natal women in Nigeria from pre-
vious studies; q = 1-p; and d = degree of accuracy/
precision expected = 0.05.
The subjects who met the criteria for inclusion into
the study were recruited after an informed consent was
obtained from the subjects. The inclusion criteria for
the study included any pregnant woman who gave con-
sent. Subjects who did not give consent were excluded
from the study. The main outcome measures were the
detection of HBV carriage status by detecting the pre-
sence of Hepatitis B surface antigen in the sera of preg-
nant women and associations between HBsAg status
and known predisposing factors, including demographic
and clinical predictors for maternal infection. Neonatal
HBV infection was also an outcome measure.
The subjects then completed an anonymous question-
naire on the predisposing factors to hepatitis B virus
infection following a literature review. The confidential-
ity of information in the questionnaire was expressed in
the introductory part of the questionnaire. The ques-
tionnaires were distribut e di na ne n v e l o p e ,w i t ha n
explanatory letter assuring anonymity. There was no
information on the questionnaire that permitted identifi-
cation of individual respondents. The self-completed
questionnaires required the subjects to fill out informa-
tion on demographics, knowledge about hepatitis B
virus and its screening and risk factors for hepatitis B
virus infection. Risk factors assessed included previous
history of blood transfusions, number of sexual partners
in the past, previous history of contact with people
infected with hepatitis B virus, history of tattoos/tribal
marks and previous history of surgical or dental proce-
dures. The questionnaires were initially pre-tested on 63
pregnant women for comprehensiveness, effectiveness,
reliability and validity. A number of minor changes were
subsequently made.
After completion of the questionnaire, five milliliters
(5 mls) of blood sample was collected from the subjects
after tourniquet application. To obtain plasma, venous
blood was collected into Ethylene Di-amine Tetra-acetic
Acid (EDTA) bottles and plasma separated for HBV
assay by centrifugation (using a centrifuge) at 6,000
revolutions per minute (rpm) for 5 minutes. Hepatitis B
surface antigen determination was then done with rapid
testing kits by applying the plasma onto the test kits.
Parallel testing for HBsAg was used for testing. Paral-
lel testing involves the use of two rapid Enzyme Linked
Immuno-Sorbent Assay (ELISA) test kits simultaneously.
The two rapid testing kits used in the study were the
hepatitis B surface antigen ELISA kits produced by
Antek diagnostics Incorporated, United Kingdom, and
Acumen diagnostic kits (Acumen diagnostics Incorpo-
rated), China. The use of two or more kits was based on
the WHO recommendation of at least two different test-
ing strategies (algorithms) involving simple rapid assays
for surveillance. A portion of plasma from each of the
subjects screened was dropped on the specimen pad on
one end of both test strips simultaneously and a waiting
time of 15 minutes was observed before the results are
read. Two simultaneously positive test results were
interpreted as positive. If one result was positive and
one negative, a third kit was used as a tie breaker to
resolve this difference (Acon Hepatitis B ultra fast diag-
nostic kits by Acon Biotech diagnostic systems, United
States of America).
The strips were pre-coated with anti-hepatitis B sur-
face antibodies (anti-HBs) on the test line region. Dur-
ing the experiment, the plasma reacted with the particle
coated with anti-HBs antibodies. The mixture migrated
on the membrane chromatographically by capillary
action and reacted with anti-HBs antibodies that gener-
ated a colored line. After 15 minutes, in the positive
samples, distinct red lines appeared in the control
region (C) and another line in the test region (T). In the
negative samples, only one red line appeared in the con-
trol region (C). The test strips were read in collabora-
tion with a Medical laboratory technologist. The results
were interpreted as follows: Positive (1
st kit), Positive
(2
nd kit) - positive result; Negative (1
st kit), Negative
(2
nd kit) - negative result; Positive (1
st kit), negative (2
nd
kit) - subject to a 3
rd test kit (tie-breaker). If positive -
positive result, if negative - negative result; Negative (1
st
kit), Positive (2
nd kit) - subject to a 3
rd test kit (tie
breaker). If positive - positive result, if negative - nega-
tive result.
The data was assessed for normality using box plots.
Statistical analysis of the results was computed using
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lysis using cross tabulations to explore statistical rela-
tionships between variables. Equality of variances
between groups was assessed before independent two-
sample t test for equal and unequal variances was used
for comparison of the means. Chi square test was used
to explore proportional relationship between groups.
The level of statistical significance was set at p < 0.05
(providing 95% confidence interval).
Results
During the 3 months study period, 480 women were
enrolled into the study. Of these, 40 tested positive to
HBsAg, accounting for 8.3% of the sample population.
T h ea g eo ft h ew o m e ns t u d i e dv a r i e df r o m1 4t o4 5
years (mean age - 24.3 years) - (Table 1). The mean par-
ity was 2.18. More than half - 264 (55.0%) of the women
had secondary level education while 124 (25.8%) and 44
(9.2%) had primary and tertiary education respectively -
(Table 1).
HBsAg was detected in 40 (8.3%) out of 480 women.
None of them were previously aware of their condition.
There were no maternal or neonatal deaths. The preva-
lence of HBsAg was highest among the 20-24 age group
(table 2), where 20 women out of the 40 tested positive
to HBsAg. The mean gestational age was 24.08 weeks.
The mean age, parity and gestational ages were not sta-
tistically significant between the HBsAg - positive and
sero-negative women. Fifty six (11.9%) of the women
sampled were HIV positive. Out of the 56 women who
tested positive to HIV, 20 (35.7%) of the respondents
who were HIV positive were also positive to HBsAg.
This was not statistically significant (P = 0.402).T h e
HIV/HBV co-infection rate from the study was therefore
(20/480 or 4.2%).
One hundred and thirty two (27.5%) women gave
a history of contact with a relative, a spouse, a friend or
someone with hepatitis B infection in the past, while
348 (72.5%) had never had contact with anyone with
hepatitis in the past (Table 3). Among those who had a
history of contact with someone with hepatitis B, 24
people tested positive to HBsAg. This was statistically
significant (c
2 = 23.11, P = 0.001, df = 1). There was no
history of hepatitis B vaccination in any of the subjects.
T h ep r e s e n c eo fb o d yi n s c r i p t i o n sl i k es c a r i f i c a t i o n
marks or tattoos were statistically significant routes of
transmission of HBV (c
2 = 27.39, P = 0.001, df = 1).-
(Table 3). Previous history of blood transfusion, history
of previous dental or surgical procedures and previous
history of circumcision/use ofs h a r p sw e r en o ts t a t i s t i -
cally significant routes of transmission of HBV.
The women’s occupation as a risk factor to the acquisi-
tion of HBsAg was also reviewed. There were 36 health-
care workers and 444 non healthcare workers sampled.
Out of the 36 healthcare workers, 8 (22.2%) tested posi-
tive to HBsAg. This was statistically significant (c
2 =
51.22, P = 0.001, df = 1). The eight women that tested
positive to HBsAg were midwives at maternity centers.
Table 1 Socio-demographic characteristics of the women
Characteristic Number (n) Percent (%)
10-14 4 0.8
15-19 72 15.0
20-24 124 34.2
25-29 88 18.3
30-34 80 16.7
35-39 56 11.7
40-44 12 2.5
45-49 4 0.8
Educational level
Primary 124 25.8
Secondary 264 55.0
Tertiary 44 9.2
No formal education 48 10.0
Religion
Christianity 472 98.3
Islam 8 1.7
Ethnicity
Igbo 456 95.0
Tiv 4 0.8
Yoruba 8 1.7
Igala 4 0.8
Urhobo 8 1.7
Occupation
Healthcare provider 36 7.5
Non health care provider 444 92.5
Marital Status
Single 20 4.2
Married 460 95.8
Table 2 Age and HBsAg status of the pregnant women
Age group (Number) HBsAg (+) HBsAg (-)
10-14 4 0 (0.0%) 4 (100.0%)
15-19 72 12 (16.7%) 60 (83.3%)
20-24 164 20 (12.2%) 144 (87.8%)
25-29 88 0 (0.0%) 88 (100.0%)
30-34 80 8(10.0%) 72 (90.0%)
35-39 56 0 (0.0%) 56 (100.0%)
40-44 12 0 (0.0%) 12 (100.0%)
45-49 4 0 (0.0%) 4 (100.0%)
X
2 = 6.237; df = 7; P = 0.512.
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factor for hepatitis B virus transmission. Ninety percent
of the women studied had at least elementary education.
Those that attained up to secondary education com-
prised the majority of the subjects - 264 (55.0%).
Among the 264 women with secondary education, 20
(7.6%) tested positive to HBV, while only 12 (9.7%) were
positive among those with primary education and 4
(9.1%) at the tertiary level respectively. This was not sta-
tistically significant (c
2 = 0.5247, P = 0.769, df = 2).
Regarding parity and hepatitis B virus infection from
the study, multigravidae (89.2%) comprised the majority
of subjects compared to primigravidae (10.8%). When
the two were compared against the risk of infection
with hepatitis B infection, there was no statistically sig-
nificant relationship between them (c
2 = 2.244, P =
0.814, df = 1).
Married subjects comprised the majority of subjects
screened for HBsAg (460 cases or 95.8%). However,
though the rest of the subjects were grouped as ‘single’,
some of these were actually co-habiting with their sexual
partners. When marital status was considered as a pre-
disposing factor to HBV infection, it was not statistically
significant (c
2 = 0.8109, P = 0.368, df = 1).
When the impact of not breastfeeding a baby when a
mother was HBV positive was assessed, 436 - (90.8%) of
the mothers stated that they would be sad if asked not
to breastfeed on account of HBV positivity. Twenty
(4.2%) said it would be okay not to breastfeed and 24
women (5%) were indifferent about breastfeeding in a
HBV sero-positive state. Infant feeding options were dis-
cussed with the women that tested positive to HBsAg
and 32 of them opted for breastfeeding.
All the 40 women that screened positive to hepatitis B
surface antigen (HBsAg) had never been screened for
HBsAg before. Also, majority of the women who
screened negative to HBsAg - 432 (91.5%) had never
been screened before. Eight women who screened nega-
tive to HBsAg had screened negative previously. On the
willingness to be screened again in subsequent pregnan-
cies, those with no formal education were significantly
unwilling to come again versus those with education.
This was shown to be statistically significant (c
2 =
61.37, P = 0.001, df = 1). Curiously enough, among
those with education, the more highly educated women
were less likely to be willing to come for re-testing.
Discussion
The results of this study showed that the prevalence of
HBsAg among pregnant women attending the antenatal
clinic in this low resource setting was 8.3%. Hence,
according to the WHO classification for Hepatitis B
endemicity, Nnewi is a hyper-endemic area for hepatitis
B virus infection. This prevalence is identical to the
Table 3 Predisposing factors to HBsAg
Variables (Number) HBsAg (+) HBsAg (-) X
2 P-value
Multiple sexual partners 480
-Yes 140 12(11.4%) 124(88.6%) 0.168 0.682
-No 340 24 (7.1%) 316 (92.9%)
Previous history of Surgery/Dental procedure 480
-Yes 112 12 (10.7%) 100 (89.3%) 1.084 0.298
-No 368 28 (7.6%) 340 (92.4%)
Previous history of Blood transfusion 480
- Yes 80 0 (0.0%) 80 (100%) 2.182 0.140
-N o 400 40 (10.0%) 360 (90.0%)
History of Circumcision 480
- Yes 96 8 (8.3%) 88 (91.7%)
-N o 252 28 (11.1%) 224 (88.9%) 1.851 0.396
- I don’t know 132 4 (3.0%) 128 (97.0%)
History of tribal marks/tattoos 480
-Yes 20 8 (40.0%) 12 (60.0%) 27.39 0.001
-No 460 32(7.0%) 428 (93.0%)
History of contact with hepatitis B infected patient in the past 480
- Yes 132 24 (18.2%) 108 (81.8%) 23.11 0.001
-N o 348 16 (4.6%) 332 (95.4%)
Previous history of sharing of sharps/needles 480
- Yes 320 32 (10.0%) 288 (90.0%) 3.490 0.062
-N o 160 8 (5.0%) 152 (95.0%)
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Zaria (ABUTH), Nigeria - 8.3% [24]. It is however,
h i g h e rt h a nt h ep r e v a l e n c eo f2 . 2 %f r o mas t u d yi n
Benin-city, Nigeria [25]. It is also higher than the
reported prevalences of 4.3% in Port-Harcourt [26],
4.4% in Lagos [10] and 4.6% in Enugu [27], all in
Nigeria. However, results from other parts of Nigeria
and Africa showed higher prevalence of HBsAg. These
i n c l u d eap r e v a l e n c eo f9 . 3 %i nA w k a[ 1 1 ] ,1 1 %i n
Makurdi [12] and 15.8% at the University of Maiduguri
Teaching Hospital (UMTH), Maiduguri, Borno state,
Nigeria [13].
In most epidemiological studies on HBsAg, there has
been a link between age and the acquisition of HBsAg.
The age of acquiring the infection is one of the major
determinants of the prevalence rates of HBsAg. In this
study, HBsAg was highest among the 20-24 age group
(Table 2). A similar finding was noted in the study by
Vazquez-Martinez et al who observed that the average
age of women infected with the Hepatitis B virus in
Mexico was 26 years [28]. The findings from this study
did not tally with the findings from the study by Habiba
et al, where majority of those that tested positive to
HBsAg were in the age range of 25-35 years [29]. The
reason for this may be because this is the age group in
which most women in South-Eastern Nigeria are most
likely to get married and become pregnant. It is also the
age when they are likely to present for the first time for
ante-natal care. Hence, those positive to HBsAg are
likely to be picked up when screened as was noted from
this study.
From the study, there was a high prevalence of HBsAg
among the pregnant women, yet, only few of the known
predisposing factors to hepatitis B virus infection
showed statistical significance. A similar result was
obtained by Summer et al when they showed that most
of those that tested positive to HBsAg had one or two
predisposing factors to hepatitis B surface antigen [30].
It was noted from this study that previous histories of
tribal marks/tattoos, occupation of the subjects and pre-
vious contact with somebody with hepatitis infection
were statistically significant predisposing factor to
HBsAg infection. The risk of transmission of HBV has
been known to be high in people who are in contact
with chronically infected subjects [6,31,32].
Another possible explanation for the high prevalence
of HBsAg among pregnant women in Nnewi, Nigeria is
that the infections could have resulted from vertical
transmission. The vertical transmission rate from this
s t u d yw a s5 1 . 6 % .T h ev e r t i c a lr o u t ei sam a j o rm o d eo f
transmission of the virus [6,7,25]. In a study done in
Benin City, Nigeria, it was shown that the vertical trans-
mission rate was 42.9% for HBsAg, which was a very
high rate of transmission, similar to the rate from this
study [25]. Multiple sexual partners, previous history of
sexually transmitted infections, previous histories of
blood transfusion and previous surgeries/dental manipu-
lations were not statistically significantly associated with
H B Vi n f e c t i o nf r o mt h i ss t u d y .T h i si si nk e e p i n gw i t h
the study in Port-Harcourt, Nigeria [26].
Out of the 56 women who tested positive to HIV,
twenty (35.7%) also tested positive to HBsAg. This was
shown not to be statistically significant. The HIV/HBV
co-infection rate from this study was 4.2%. This rate is
higher than the 0.7% HIV/HBV co-infection rate among
pregnant women screened in Awka, Nigeria [10], but
less than a co-infection rate of 11.5% in Jos, Nigeria
[33]. The result of this study corroborated with some
other studies in Africa that have shown HIV/HBV co-
i n f e c t i o nt ob el o w .As t u d yi nM a l a w ib yA h m e de ta l
showed that there was no statistical evidence to suggest
that HIV positivity was associated with an increased pre-
valence of HBV [34]. Another study among pregnant
women attending ante-natal clinics in Burkina Faso
showed a low co-infection rate of 0.88% [35]. HIV/HBV
co-infection was also very low (0.20%) in a study in
Benin- city, Nigeria where it was concluded that obste-
tric co-infection with HIV and HBV was a rare phenom-
enon in their parturients [25].
Another important factor studied was the link
between the level of education of the pregnant women
and the acquisition of HBV as well as the willingness to
be re-tested for HBsAg in subsequent pregnancies.
Ninety percent of the women studied had at least ele-
mentary education. This finding was in keeping with the
study in Mexico, which showed that the educational sta-
tus of the population was high since 78% of the women
studied had at least elementary education [28]. It was
also noted that the education of the women appeared to
improve respondent’s willingness to accept testing and
re-testing in subsequent pregnancies, be it primary, sec-
ondary or tertiary education. However, those with no
formal education were significantly unwilling to come
again versus those with education. Curiously enough,
among those with education, the more highly educated
one was, the less likely they were willing to come for re-
testing. The reason for this may be that those with ter-
tiary education felt that testing once for the HBsAg was
enough irrespective of whether or not they were repeat-
edly exposed to predisposing factors to HBsAg. They
might think that re-testing would be a waste of time.
Hence, from this study, it is important to educate
women on the need for repeated testing, at least once in
every pregnancy during antenatal care sessions.
Occupation of the subjects is a known predisposing
factor for HBsAg infection [36]. From the study, eight
out of the 36 health care workers (22.2%) screened posi-
tive to HBsAg. This was statistically significant. It is
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posed to know about the modes of transmission of
HBsAg and thus, protect themselves from getting
infected. However, those in high risk health departments
like blood transfusion services or theatres may be more
predisposed to acquiring the infection compared to
health care workers in pharmacies, out-patient depart-
ments and administrative departments of hospitals. The
fact that the eight pregnant women that tested positive
to HBsAg were midwives at maternities goes further to
buttress the point. As midwives, they were exposed to
body fluids from women during delivery and possibly
acquired the infection from body fluids from these
women at delivery. This study also showed expectedly
that health workers were significantly more likely to
have heard about screening for HBsAg, compared to
their non health care counterparts.
The study also showed that majority of the mothers
(97%) wanted to breastfeed their babies even when
infected with HBV. There is evidence that HBV can be
transmitted from infected mothers to their babies
through breast milk [18,19,21]. Therefore, avoidance of
breastfeeding lowers the risk of HBV transmission from
an infected mother to the baby. On the other hand, non
breastfed infants are prone to serious health risks,
including diarrheal disease and other infections in
infancy. Infant feeding options were discussed with the
women that tested positive to HBsAg and 32 of them
opted for breastfeeding.
T h e r ew e r es o m el i m i t a t i o n st ot h i ss t u d y .T h es t u d y
was done in a single low resource centre in Nigeria. Even
though the study was done in a single low resource center,
it is a very big referral center for urban and especially,
rural pregnant women in South-eastern Nigeria. So, it is a
good place to do research because of the diversity of
patients managed in this center. It was also a cross-sec-
tional study. In future, when funds become available, a
prospective multi-centre study would be carried out to
further validate our findings. The strength of our study is
in the fact that it was carried out in a low resource region
not previously studied. The study also highlights the major
routes of transmission of the hepatitis B virus in this low
resource setting in Nigeria, and the current challenges as
regards routine screening of women in pregnancy, and
vaccinating newborns immediately after delivery. The
study was able to show that vertical transmission of the
virus was the commonest route of transmission in low
resource settings in South-eastern Nigeria.
Conclusion
The results of this study highlighted the high prevalence
and correlates of HBsAg in Nnewi, Nigeria and its pat-
tern among pregnant women attending antenatal care.
Despite the high prevalence of HBsAg from the study,
there was a low pick up rate based only on predisposing
factors to hepatitis B virus. The high prevalence under-
scores the need for preventive measures against hepatitis
B virus infection in pregnant women. It also underscores
the need for routine testing of the virus in pregnant
women during antenatal sessions. With increased cam-
paign for testing, it is believed that more success will be
made in this area. Thus, it is imperative that women be
properly educated by healthcare personnel on the
v a r i o u sr o u t e so ft r a n s m i s s i o no ft h ev i r u s ,t h ei n f a n t
feeding options available and the need for screening and
re-screening for HBsAg in pregnancy. There is also
need for treatment of positive cases to prevent mother
to child transmission of HBV.
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